Advancing the Care in Thoracic Cancer: Emerging Treatment Options

Access Course


9fcc4845-b7a8-4518-b7c8-171470014791.jpgRead three articles that review immunotherapy treatment options in mesothelioma, small cell lung cancer, and non-small cell lung cancer.

This activity is intended for hematology/oncology specialists, pulmonologists, and pathologists.

The goal of this activity is to increase awareness of immunotherapy as a treatment option for extensive disease in thoracic cancers.



Approximate Time to Complete: 1 hour


Course Available Beginning: Nov. 30, 2016


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Identify barriers to optimizing outcomes with immunotherapy
  • Evaluate emerging efficacy data on the use of cancer immunotherapies in the management of thoracic cancer